Login / Signup

Progress of Induced Pluripotent Stem Cell Technologies to Understand Genetic Epilepsy.

Bruno SterliniFloriana FruscioneSimona BaldassariFabio BenfenatiFederico ZaraAnna Corradi
Published in: International journal of molecular sciences (2020)
The study of the pathomechanisms by which gene mutations lead to neurological diseases has benefit from several cellular and animal models. Recently, induced Pluripotent Stem Cell (iPSC) technologies have made possible the access to human neurons to study nervous system disease-related mechanisms, and are at the forefront of the research into neurological diseases. In this review, we will focalize upon genetic epilepsy, and summarize the most recent studies in which iPSC-based technologies were used to gain insight on the molecular bases of epilepsies. Moreover, we discuss the latest advancements in epilepsy cell modeling. At the two dimensional (2D) level, single-cell models of iPSC-derived neurons lead to a mature neuronal phenotype, and now allow a reliable investigation of synaptic transmission and plasticity. In addition, functional characterization of cerebral organoids enlightens neuronal network dynamics in a three-dimensional (3D) structure. Finally, we discuss the use of iPSCs as the cutting-edge technology for cell therapy in epilepsy.
Keyphrases
  • cell therapy
  • stem cells
  • induced pluripotent stem cells
  • single cell
  • cerebral ischemia
  • high glucose
  • spinal cord
  • diabetic rats
  • oxidative stress
  • drug induced
  • subarachnoid hemorrhage
  • bone marrow
  • single molecule